News | February 10, 2011

Hospital Study Demonstrates CT System’s Cost Savings With Stroke

February 10, 2011 – A study at Millard Fillmore Circle Gates Hospital in Buffalo, N.Y., found that Toshiba imaging equipment presented significant benefits, both for the patients and hospital.

To quantify the results of utilizing the Aquilion ONE for acute stroke, the hospital conducted a non-controlled study to measure the impact of 320-detector row dynamic volume CT. It evaluated data from before and after the system’s installation and addressed the top three discharging ICD-9-CM codes.

Prior to installing the system, most patients were imaged using pre-MRI screening and X-ray imaging, limited brain MRI, MR perfusion and MRA of the head and neck. Utilizing the Aquilion ONE showed a significant shift in the diagnostic workup for acute stroke. The expanded use of CT during stroke diagnosis resulted in reduced healthcare costs and improved patient outcomes, as MR is more user-intensive and costly. Furthermore, the images produced by CT allowed patients to be moved more quickly into intervention.

“With stroke accounting for 1 in every 18 deaths in the U.S. and costing the healthcare system approximately $50 billion a year, advanced imaging technologies are allowing us to diagnose stroke more accurately and efficiently than ever before,” said Elad Levy, M.D., FACS, FAHA, professor of Neurosurgery, University at Buffalo Neurosurgery, and director of endovascular stroke service for the Gates Stroke Center. “The whole brain perfusion and digital angiography capabilities of the Aquilion ONE provide our clinicians with the information needed to evaluate the penumbra or the region impacted by the stroke, quickly and accurately.”

On average, patients who were scanned on the system had their hospital stay reduced by nearly half a day. Additionally, for just the three ICD-9-CM codes studied, Millard Fillmore achieved an estimated annualized savings of more than $750,000 by utilizing the system to diagnose acute stroke.

For more information: www.medical.toshiba.com

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Cardiac Imaging| August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | FFR Catheters| August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Overlay Init